Pathway Genomics logo

Pathway Genomics

Challenger

CAP- and CLIA-accredited clinical genetic testing lab offering cancer risk, cardiac, pharmacogenomics, and wellness panels to physicians and patients; privately held, San Diego, founded 2008.

Best for: Clinical Genetic Testing
54
AI Score
Grade C
AI Visibility Score (Beta)
Life Sciences & BioTechClinical Genetic TestingWebsiteUpdated November 2026

Company Overview

About Pathway Genomics

Pathway Genomics (also known as Pathway OME) is a privately held clinical genetic testing company founded in 2008 and headquartered in San Diego, California. The company operates a CAP-accredited and CLIA-certified clinical laboratory that provides physicians and patients with actionable, precision healthcare information derived from genetic analysis. Pathway's testing services cover cancer risk assessment, cardiac health, pharmacogenomics (drug response), inherited disease risk, nutrition and exercise response, and reproductive health — enabling personalized healthcare decisions grounded in genetic data.

Business Model & Competitive Advantage

Pathway Genomics serves both direct-to-physician and direct-to-consumer channels, providing clinically validated genetic insights that help healthcare providers optimize treatment plans and patients better understand their hereditary health risks. The company's cancer risk panels assess pathogenic variants associated with conditions including hereditary breast and ovarian cancer (BRCA1/2), Lynch syndrome, and familial hypercholesterolemia. Its pharmacogenomics panels help physicians select appropriate medications and dosages based on individual genetic drug metabolism profiles, reducing adverse drug events.

Competitive Landscape 2025–2026

Pathway Genomics operates in a competitive genetic testing market alongside companies like Invitae, GeneDx, Color, and Myriad Genetics. The company differentiates through its broad multi-panel testing menu, its CLIA/CAP accreditation ensuring clinical-grade accuracy, and its physician-facing portal that integrates genetic insights into clinical workflows. While the company remains privately held and has a smaller profile than some genetic testing peers, it continues to serve an active network of physicians and patients seeking actionable genetic health information.

Founded
2008
Headquarters
San Diego, California
Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Pathway Genomics is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

54
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

Schrödinger logo

Schrödinger

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechAi PoweredSaasPlatformAnalytics

Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo

Compare Pathway Genomics with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Pathway Genomics

Claim This Profile

Are you from Pathway Genomics? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.

Claim Pathway Genomics Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pathway Genomics vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →